Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CRIPTO pseudogene 6 is a **processed pseudogene**, meaning it is a genomically encoded sequence with high similarity to the parental CRIPTO gene but lacking the ability to produce a functional protein.[4][2][3] Pseudogenes are generally products of ancient gene duplication or retrotransposition; they can sometimes participate in regulatory roles at the RNA level, such as acting as microRNA sponges (competitive endogenous RNA, or ceRNA), but there is no direct evidence for this function specific to CRIPTOP6[5]. It does not encode any receptor or molecular target, does not participate in canonical signaling pathways, and is not implicated as a therapeutic target, biomarker, or drug-interacting protein. Its identification as a pseudogene is clear, and its designation as a pharmacological target is **incorrect**.
None (no known mechanisms, since it does not encode a functional protein or target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CRIPTO pseudogene 6 (CRIPTOP6).